Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 15456273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase.

  2004cited by this paper
• Arresting Initiation of Hepatitis C Virus RNA Synthesis Using Heterocyclic Derivatives*

  2003cited by this paper
• Dynamics of Subgenomic Hepatitis C Virus Replicon RNA Levels in Huh-7 Cells after Exposure to Nucleoside Antimetabolites

  2003cited by this paper
• Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase.

  2003cited by this paper
• Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs*

  2003cited by this paper
• Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro*

  2003cited by this paper
• Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase*

  2002cited by this paper
• Structural Analysis of the Hepatitis C Virus RNA Polymerase in Complex with Ribonucleotides

  2002cited by this paper
• A mechanism for initiating RNA-dependent RNA polymerization

  2001cited by this paper
• Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization.

  1997cited by this paper
• Identification and properties of the RNA‐dependent RNA polymerase of hepatitis C virus.

  1996cited by this paper
• Structure and organization of the hepatitis C virus genome isolated from human carriers

  1991cited by this paper
• Synthesis, antiproliferative, and antiviral activity of certain 4-substituted and 4,5-disubstituted 7-[(1,3-dihydroxy-2-propoxy)methyl]pyrrolo[2,3-d]pyrimidines.

  1990cited by this paper
• Synthesis and antiviral activity of certain 4- and 4,5-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.

  1988cited by this paper

• Potent Competitive Inhibitors of Ecto-5'-nucleotidase (CD73) based on 6‑(Het)aryl-7-deazapurine Ribonucleoside 5'‑O‑Bisphosphonates.

  2025cites this paper
• Combating yellow fever virus with 7-deaza-7-fluoro-2′-C-methyladenosine

  2025cites this paper
• Discovery of a 2'-α-Fluoro-2'-β-C-(fluoromethyl) Purine Nucleotide Prodrug as a Potential Oral Anti-SARS-CoV-2 Agent.

  2025cites this paper
• Recent Progress in the Discovery of Anti‐Mpox Agents

  2025cites this paper
• Small molecule direct-acting antivirals for treatment of mpox.

  2025cites this paper
• A Quick and Sensitive LC-MS/MS Method for Simultaneous Quantification of Sofosbuvir Metabolite (GS-331007) in Human Plasma: Application to Hepatitis C Infected Patients with End-Stage Renal Disease

  2024cites this paper
• Orally available nucleoside analog UMM-766 provides protection in a murine model of orthopox disease

  2024influential citation
• The 2’-C-Methylribonucleoside of 5-Aza-7-deaza-7-iodoguanine: Hydrogen and Halogen Bonding in Nucleoside Crystals, Synthesis and Physical Properties

  2023cites this paper
• Synthesis and biological evaluation of Ribo 7-N/O/S pyrimidine 9-deaza C-nucleoside analogs as new antiviral agents for inhibiting HCV RNA-dependent RNA polymerases.

  2023cites this paper
• Competing interests during the key N-glycosylation of 6-chloro-7-deaza-7-iodopurine for the synthesis of 7-deaza-2′-methyladenosine using Vorbrüggen conditions

  2023cites this paper
• Synthesis of novel azasugar-containing 2'β-C-Me 9-deaza nucleosides as potential anti-hepatitis C virus agents

  2022cites this paper
• Special Collection: A pioneer in antiviral drug discovery and development: Commemorating John Martin-Review

  2022cites this paper
• Nucleosides and emerging viruses: A new story

  2022cites this paper
• Discovery of a 2′-Fluoro,2′-Bromouridine Phosphoramidate Prodrug Exhibiting Anti-Yellow Fever Virus Activity in Culture and in Mice

  2022cites this paper
• Intriguing Antiviral Modified Nucleosides: A Retrospective View into the Future Treatment of COVID-19

  2021cites this paper
• Nucleoside analogue inhibitors for Zika virus infection

  2021cites this paper
• Antiviral therapeutics directed against RNA dependent RNA polymerases from positive-sense viruses.

  2021cites this paper
• Repurposing Nucleoside Analogs for Human Coronaviruses

  2020cites this paper
• Synthesis of 7-trifluoromethyl-7-deazapurine ribonucleoside analogs and their monophosphate prodrugs

  2020cites this paper
• Synthesis and Cytotoxic and Antiviral Activity Profiling of All-Four Isomeric Series of Pyrido-Fused 7-Deazapurine Ribonucleosides.

  2020cites this paper
• Synthesis and Antiviral Activity of a Series of 2′-C-Methyl-4′-thionucleoside Monophosphate Prodrugs

  2020cites this paper
• Quick and Sensitive UPLC-ESI-MS/MS Method for Simultaneous Estimation of Sofosbuvir and Its Metabolite in Human Plasma

  2019cites this paper
• Synthesis and Anti‐HIV Activity of Guanine Modified Fluorinated Acyclic Nucleoside Phosphonate Derivatives

  2019cites this paper
• Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses

  2019cites this paper
• Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.

  2019cites this paper
• Asymmetric Synthesis of 2'-C-Methyl-4'-selenonucleosides as Anti-Hepatitis C Virus (HCV) Agents.

  2019cites this paper
• Evolution of HCV NS5B Nucleoside and Nucleotide Inhibitors

  2019cites this paper
• Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus

  2019cites this paper
• Does HCV RNA polymerase accept 2â-Deoxynucleosides as itssubstrates?

  2018cites this paper
• Concentration of 2′C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase

  2018cites this paper
• The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold

  2018influential citation
• Facile synthesis of 2-C-methyl-d-arabino-γ-1,4-lactones and mechanism study

  2018cites this paper
• Synthesis and biological evaluation of a novel β-D-2'-deoxy-2'-α-fluoro-2'-β-C-(fluoromethyl)uridine phosphoramidate prodrug for the treatment of hepatitis C virus infection.

  2018cites this paper
• Nucleosides for the treatment of respiratory RNA virus infections

  2018cites this paper
• Synthesis of Antitumor Fluorinated Pyrimidine Nucleosides

  2017cites this paper
• Synthesis Strategies and Biological Value of Pyrrole and Pyrrolopyrimidine

  2017cites this paper
• 2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture.

  2017cites this paper
• Towards interference free HPLC‐SERS for the trace analysis of drug metabolites in biological fluids

  2017cites this paper
• Pyrrolo[2,3‐d]pyrimidine (7‐deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides

  2017cites this paper
• Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection

  2017cites this paper
• Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor

  2017cites this paper
• Synthesis and antiviral evaluation of base-modified deoxythreosyl nucleoside phosphonates.

  2017cites this paper
• Development of C-Methyl Branched Purine Ribonucleoside Analogs: Chemistry, Biological Activity and Therapeutic Potential.

  2016cites this paper
• Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review.

  2016cites this paper
• Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.

  2016cites this paper
• Selected organophosphorus compounds with biological activity. Applications in medicine

  2016cites this paper
• Synthetic Entries to and Biological Activity of Pyrrolopyrimidines.

  2016cites this paper
• Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling

  2016cites this paper
• A REVIEW ON ANTI-HCV AGENTS TARGETING ACTIVE SITE AND ALLOSTERIC SITES OF NON-STRUCTURAL PROTEIN 5B [NS5B]

  2016cites this paper
• Novel and sensitive UPLC-MS/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study.

  2016cites this paper
• Ledipasvir/sofosbuvir fixed-dose combination for treatment of hepatitis C virus genotype 4 infection.

  2016cites this paper
• Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities.

  2015cites this paper
• Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study.

  2015cites this paper
• The search for nucleoside/nucleotide analog inhibitors of dengue virus.

  2015cites this paper
• Synthesis of [18F]Arenes via the Copper-Mediated [18F]Fluorination of Boronic Acids

  2015cites this paper
• 2‐Substituted 6‐(Het)aryl‐7‐deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity

  2015cites this paper
• NMR-based conformational analysis of 2',6-disubstituted uridines and antiviral evaluation of new phosphoramidate prodrugs.

  2015cites this paper
• Design, synthesis and antiviral evaluation of 2'-C-methyl branched guanosine pronucleotides: the discovery of IDX184, a potent liver-targeted HCV polymerase inhibitor.

  2015cites this paper
• Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors.

  2015cites this paper
• Syntheses of nucleosides with a 1′,2′-β-lactam moiety as potential inhibitors of hepatitis C virus NS5B polymerase

  2014cites this paper
• Synthesis of Purine and 7‐Deazapurine Nucleoside Analogues of 6‐N‐(4‐Nitrobenzyl)adenosine; Inhibition of Nucleoside Transport and Proliferation of Cancer Cells

  2014cites this paper
• Chemistry of Fluorinated Indoles

  2014cites this paper
• Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.

  2014cites this paper
• moieties as potential inhibitors of hepatitis C virus NS5B polymerase

  2014cites this paper
• A New Paradigm for Developing Antiviral Drugs Exemplified by the Development of Supremely High Anti-HIV Active EFdA

  2014cites this paper
• Sofosbuvir for the treatment of chronic hepatitis C virus infection.

  2014cites this paper
• Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B

  2014cites this paper
• Recent highlights in the synthesis of anti-HCV ribonucleosides.

  2014cites this paper
• Synthesis of 2'-O,4'-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase.

  2014cites this paper
• 7-Cyclopropyl-2'-deoxytubercidin: a carbocyclic side-chain derivative of 7-deaza-2'-deoxyadenosine.

  2014cites this paper
• A Convenient Route for the Synthesis of 3‐Deazaspongosine

  2014cites this paper
• Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design

  2013cites this paper
• Development of 2′-Deoxy-4′-C-Ethynyl-2-Fluoroadenosine (EFdA) which has Supremely High Anti-HIV Activity and Low Toxicity and Prevents the Emergence of Resistant HIV Mutants, and Discovery of Different SubstrateSelectivity between Viral and Human Nucleic Acid Polymerases

  2013cites this paper
• Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial.

  2013cites this paper
• ENZYMATICALLY ACTIVATED PHOSPHATE AND PHOSPHONATE PRODRUGS

  2013cites this paper
• Transition-metal-free carbofluorination of TBS-protected nitrogen-containing cyclic enynols: synthesis of fluorinated azabicycles.

  2013cites this paper
• A New Route for the Synthesis of 4-Amino-5-Fluoro-7-(2′-Deoxy-2′-Fluoro-2′-C-Methyl-β-d- Ribofuranosyl)-1H-Pyrrolo[2,3-D]Pyrimidine

  2013cites this paper
• Unravelling the versatile metal binding modes of adenine: Looking at the molecular recognition patterns of deaza- and aza-adenines in mixed ligand metal complexes

  2013cites this paper
• Synthesis and evaluation against hepatitis C virus of 7-deaza analogues of 2'-C-methyl-6-O-methyl guanosine nucleoside and L-Alanine ester phosphoramidates.

  2013cites this paper
• A Conformational Mimetic Approach for the Synthesis of Carbocyclic Nucleosides as Anti‐HCV Leads

  2013cites this paper
• Synthesis and evaluation of Janus type nucleosides as potential HCV NS5B polymerase inhibitors.

  2013cites this paper
• Evaluation of 2'-α-fluorine modified nucleoside phosphonates as potential inhibitors of HCV polymerase.

  2013cites this paper
• Nucleotide prodrugs for the treatment of HCV infection.

  2013cites this paper
• Different molecular mechanisms of inhibition of bovine viral diarrhea virus and hepatitis C virus RNA-dependent RNA polymerases by a novel benzimidazole.

  2013cites this paper
• Stereoselective synthesis of C-2-methylene and C-2-methyl-C-glycosides by Claisen rearrangement of 2-vinyloxymethyl glycals

  2012cites this paper
• Synthesis and Antiviral Properties of Novel Tetracyclic Nucleoside Inhibitors of Hepatitis C NS5B Polymerase

  2012cites this paper
• Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase.

  2012cites this paper
• Sugar-modified derivatives of cytostatic 7-(het)aryl-7-deazaadenosines: 2'-C-methylribonucleosides, 2'-deoxy-2'-fluoroarabinonucleosides, arabinonucleosides and 2'-deoxyribonucleosides.

  2012cites this paper
• Hepatitis C RNA-dependent RNA polymerase inhibitors: a review of structure-activity and resistance relationships; different scaffolds and mutations.

  2012cites this paper
• Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral Ribonucleosides

  2012cites this paper
• 7-Deazapurine (Pyrrolo[2,3-d]pyrimidine) 2-Deoxyribonucleosides: Syntheses and Transformations

  2012cites this paper
• Selected Applications of Pd‐ and Cu‐Catalyzed Carbon–Heteroatom Cross‐Coupling Reactions in the Pharmaceutical Industry

  2012cites this paper
• Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase.

  2012cites this paper
• Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na(v)1.7 antagonists.

  2012cites this paper
• Structure based medicinal chemistry approach to develop 4-methyl-7-deazaadenine carbocyclic nucleosides as anti-HCV agent.

  2012cites this paper
• 4’-C-Ethynyl-2-Fluoro-2’-Deoxyadenosine (EFdA): A Two Site Modified 2’-Deoxyadenosine Derivative which Could Prevent the Emergence of Resistant HIV Mutant and has Supremely High Anti-HIV Activity and Low Toxicity

  2012cites this paper
• Synthesis and applications of fluorinated nucleoside analogues

  2012cites this paper
• Synthesis of pyrrolo[2,3-d]pyrimidines with 3-amino-2-hydroxypropyl substituents

  2012cites this paper
• N-{3-[2-(4-Fluorophenoxy)ethyl]-2,4-dioxo-1,3-diazaspiro[4.5]decan-7-yl}-4-methylbenzamide

  2011cites this paper
• Stereoselective synthesis of PSI-352938: a β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyl-3',5'-cyclic phosphate nucleotide prodrug for the treatment of HCV.

  2011cites this paper